Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the prospect of bankruptcy. A resounding 93% of the company’s shareholders voted in favour of the move. This provides CEO…
Tag: Corporate Strategy
-
AfroCentric’s JSE Collapse Fuels a New Healthcare Empire
As insurance giant Sanlam tightens its grip on health-fin services specialist AfroCentric, the line between public company and private control has all but vanished. What remains is a powerful lesson in strategic patience. It reveals how corporations (or businesses) can methodically turn market neglect into a corporate opportunity. While AfroCentric still technically trades on the JSE, its story is no…
-
Dis-Chem’s Strategy Towards Healthcare Integration
Dis-Chem CEO Rui Morais has declared that the pharmacy group’s ongoing transformation is no longer just about Dis-Chem’s strategy or market share, but about its people. While rivals in the consolidating South African pharmacy market bet on scale and diversification, Morais, who took the helm in 2023, believes the company’s most considerable success lies in fundamentally reshaping its internal culture.…
-
Mediclinic AI Strategy Targets R2 Billion Savings Amid Job Freezes
Mediclinic announced major operational changes. The hospital group aims to achieve R2 billion in annual savings. Mediclinic set this goal for the 2027 financial year. A pivot to Artificial Intelligence drives this shift. This forms the core of the new Mediclinic AI strategy. Mediclinic is transforming its corporate landscape. It has frozen new non-essential hires. Mediclinic now offers voluntary severance…